Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey.

[1]  G. de Simone,et al.  A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[2]  B. Iung,et al.  TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. , 2016, European heart journal.

[3]  J. Leipsic,et al.  Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.

[4]  A. Regueiro,et al.  Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis , 2016, Circulation. Cardiovascular interventions.

[5]  K. Alexander,et al.  Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry , 2016, Circulation.

[6]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[7]  S. Rex,et al.  General or Local Anesthesia for TAVI? A Systematic Review of the Literature and Meta-Analysis. , 2016, Current pharmaceutical design.

[8]  A. Regueiro,et al.  Balancing the Risks of Thrombosis and Bleeding Following Transcatheter Aortic Valve Implantation: Current State-of-Evidence. , 2016, Current pharmaceutical design.

[9]  R. Lange,et al.  1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study. , 2016, JACC. Cardiovascular interventions.

[10]  J. Carroll,et al.  Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. , 2016, The Annals of thoracic surgery.

[11]  N. Weissman,et al.  Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study. , 2016, JACC. Cardiovascular interventions.

[12]  J. Carroll,et al.  Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. , 2015, Journal of the American College of Cardiology.

[13]  T. Lüscher,et al.  Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement , 2015, PloS one.

[14]  C. Macaya,et al.  Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement. , 2015, JACC. Cardiovascular interventions.

[15]  P. Leprince,et al.  Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: Results From the FRANCE-2 Registry. , 2015, JACC. Cardiovascular interventions.

[16]  M. Mack,et al.  Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). , 2015, The American journal of cardiology.

[17]  A. Colombo,et al.  5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis. , 2015, JACC. Cardiovascular interventions.

[18]  L. W. Andersen,et al.  Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.

[19]  R. Lange,et al.  Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. , 2015, Journal of the American College of Cardiology.

[20]  B. Gage,et al.  Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement , 2015, Heart.

[21]  John D. Carroll,et al.  Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.

[22]  P. Lemos,et al.  Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. , 2015, Journal of the American College of Cardiology.

[23]  M. Mack,et al.  Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. , 2014, Journal of the American College of Cardiology.

[24]  M. Mack,et al.  The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial. , 2014, The Journal of thoracic and cardiovascular surgery.

[25]  R. Jeger,et al.  Pacemaker Implantation and Need for Ventricular Pacing during Follow‐Up after Transcatheter Aortic Valve Implantation , 2014, Pacing and clinical electrophysiology : PACE.

[26]  Jeroen J. Bax,et al.  Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. , 2014, European heart journal.

[27]  Raimund Erbel,et al.  Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. , 2014, European heart journal.

[28]  Tim Beißbarth,et al.  Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: risk assessment by Katz Index of activities of daily living. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[29]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[30]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[31]  M. Mack,et al.  Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial , 2014, Circulation.

[32]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[33]  J. Mehilli,et al.  Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. , 2014, JAMA.

[34]  A. Cheung,et al.  Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. , 2014, JACC. Cardiovascular interventions.

[35]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[36]  J. Mega,et al.  Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. , 2013, Journal of the American College of Cardiology.

[37]  M. Mack,et al.  Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). , 2013, The American journal of cardiology.

[38]  P. Pibarot,et al.  Prognostic value of exercise capacity as evaluated by the 6-minute walk test in patients undergoing transcatheter aortic valve implantation. , 2013, Journal of the American College of Cardiology.

[39]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[40]  D. Wood,et al.  Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. , 2012, Journal of the American College of Cardiology.

[41]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[42]  P. Jüni,et al.  Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. , 2012, JACC. Cardiovascular interventions.

[43]  Cornelius Müller,et al.  Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. , 2012, Journal of the American College of Cardiology.

[44]  P. Pibarot,et al.  Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. , 2012, Journal of the American College of Cardiology.

[45]  Pascal Vranckx,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[46]  D. Capodanno,et al.  Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. , 2011, The American journal of cardiology.

[47]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[48]  Á. Cequier,et al.  Atrioventricular Conduction Disturbance Characterization in Transcatheter Aortic Valve Implantation With the CoreValve Prosthesis , 2011, Circulation. Cardiovascular interventions.

[49]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.